Wockhardt now intends to file a new drug application (NDA) with the USFDA and seek marketing authorisation application with ...

The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus ...

Zaynich could play a key role in treating patients suffering from complicated urinary tract infections caused by ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

In this article, we will take a look at the 12 stocks that will double in 2025.

Levi Garraway, Roche’s chief medical officer and head of global product development, said: “The INAVO120 overall survival ...

As such, the tech giant is conducting a limited test of ads on Threads with a small number of advertisers, allowing them to extend their existing Meta ad campaigns to the app while the service ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ImmunityBio, Inc. (NASDAQ:IBRX) stands against the other stocks. The Fed’s ...

Sanofi’s Sarclisa (isatuximab) has been approved by the Medicines and Healthcare product Regulatory Agency (MHRA) as part of a combination treatment for newly diagnosed multiple myeloma (MM).

Hastings and Andreas Wicki, PhD Retire from Board of Directors -- PARSIPPANY, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Pacira ...

To report SUSPECTED ADVERSE REACTIONS, contact Zevra Therapeutics, Inc. at toll-free phone 1-844-600-2237 or FDA at 1‑800-FDA-1088 or www.fda.gov/medwatch.

International investigators have arrested 418 suspects as part of an operation targeting the trade of fake medicines and illicit substances in 30 countries, the European Union's law enforcement body ...